Try a new search

Format these results:

Searched for:

in-biosketch:yes

person:morgag04

Total Results:

677


Tobacco and alcohol consumption and the risk of non-Hodgkin lymphoma

Willett, Eleanor V; Smith, Alexandra G; Dovey, Gareth J; Morgan, Gareth J; Parker, Jan; Roman, Eve
OBJECTIVE:The aim was to test whether non-Hodgkin lymphoma (NHL) is associated with smoking or alcohol. METHODS:A case-control study recruited NHL cases aged 18-64 in parts of England between 1998 and 2001. One control was matched to each case on sex, date of birth and area of residence. Self-reported histories of tobacco and alcohol consumption were collected during face-to-face interviews. RESULTS:Among 700 cases and 915 controls, no association of smoking with the risk of NHL was observed [odds ratio (OR) = 1.04, 95% confidence interval (CI): 0.85-1.28]. Risks were not raised with age started smoking, number of years smoked, and number of years stopped smoking. Compared with persons who drank alcohol once or twice a week, neither abstainers (OR = 1.03, 95% CI: 0.64-1.67), nor consumers of alcohol one to five times a year (OR = 1.35, 95% CI: 0.95-1.93), one to two times a month (OR = 1.20, 95% CI: 0.87-1.65), three to four times a week (OR = 0.82, 95% CI: 0.62-1.10), or most days (OR = 0.94, 95% CI: 0.70-1.25) increased their risk of developing NHL. Average daily volume or high occasional alcohol consumption were not associated with NHL. CONCLUSIONS:NHL was not associated with smoking or alcohol, but collaborative studies could further investigate the risks of rarer WHO subtypes following these exposures.
PMID: 15456990
ISSN: 0957-5243
CID: 3650092

Application of DNA pooling to large studies of disease

Law, Graham R; Rollinson, Sara; Feltbower, Richard; Allan, James M; Morgan, Gareth J; Roman, Eve
Large collections of individuals are required to investigate the association of commonly occurring genetic variation with disease. The laboratory assessment of one form of variation, single nucleotide polymorphisms, is costly in time and DNA. Robust statistical approaches are developed to allow the successful implementation of a recently described laboratory method for rapidly estimating allele frequency using pools of DNA. A substantial reduction in Type I error is demonstrated using simulation, through the incorporation of measurement error into confidence limits for a case-control study, illustrated on a case-control study of acute leukaemia in adults. A method for creating multiple sub-pools is described which will allow large studies, such as the proposed U.K. Biobank, to take advantage of this method. Furthermore, a set-based logistic regression is presented which allows the investigation of joint effects and interactions with other genes or environmental factors.
PMID: 15580596
ISSN: 0277-6715
CID: 3650102

Association of metabolic gene polymorphisms with tobacco consumption in healthy controls

Smits, Kim M; Benhamou, Simone; Garte, Seymour; Weijenberg, Matty P; Alamanos, Yannis; Ambrosone, Christine; Autrup, Herman; Autrup, Judith L; Baranova, Helena; Bathum, Lisa; Boffetta, Paolo; Bouchardy, C; Brockmoller, Jurgen; Butkiewicz, Dorota; Cascorbi, Ingolf; Clapper, Margie L; Coutelle, Christiane; Daly, Ann K; Muzi, Giacomo; Dolzan, Vita; Duzhak, Tatyana G; Farker, Katrin; Golka, Klaus; Haugen, Aage; Hein, David W; Hildesheim, Allan; Hirvonen, Ari; Hsieh, Ling L; Ingelman-Sundberg, Magnus; Kalina, Ivan; Kang, Daehee; Katoh, Takahiko; Kihara, Masahiro; Ono-Kihara, Masako; Kim, Heon; Kiyohara, Chikako; Kremers, Pierre; Lazarus, Philip; Le Marchand, Loic; Lechner, Maria C; London, Stephanie; Manni, Johannes J; Maugard, Christine M; Morgan, Gareth J; Morita, Shunji; Nazar-Stewart, Valle; Kristensen, Vessela Nedelcheva; Oda, Yoshio; Parl, Fritz F; Peters, Wilbert H M; Rannug, Agneta; Rebbeck, Timothy; Pinto, Luis F Ribeiro; Risch, Angela; Romkes, Marjorie; Salagovic, Jan; Schoket, Bernadette; Seidegard, Janeric; Shields, Peter G; Sim, Edith; Sinnett, Daniel; Strange, Richard C; Stucker, Isabelle; Sugimura, Haruhiko; To-Figueras, Jordi; Vineis, Paolo; Yu, Mimi C; Zheng, Wei; Pedotti, Paola; Taioli, Emanuela
Polymorphisms in genes that encode for metabolic enzymes have been associated with variations in enzyme activity between individuals. Such variations could be associated with differences in individual exposure to carcinogens that are metabolized by these genes. In this study, we examine the association between polymorphisms in several metabolic genes and the consumption of tobacco in a large sample of healthy individuals. The database of the International Collaborative Study on Genetic Susceptibility to Environmental Carcinogens was used. All the individuals who were controls from the case-control studies included in the data set with information on smoking habits and on genetic polymorphisms were selected (n = 20938). Sufficient information was available on the following genes that are involved in the metabolism of tobacco smoke constituents: CYP1A1, GSTM1, GSTT1, NAT2 and GSTP1. None of the tested genes was clearly associated with smoking behavior. Information on smoking dose, available for a subset of subjects, showed no effect of metabolic gene polymorphisms on the amount of smoking. No association between polymorphisms in the genes studied and tobacco consumption was observed; therefore, no effect of these genes on smoking behavior should be expected.
PMID: 15069692
ISSN: 0020-7136
CID: 2189482

Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin

Ashcroft, A J; Cruickshank, S M; Croucher, P I; Perry, M J; Rollinson, S; Lippitt, J M; Child, J A; Dunstan, C; Felsburg, P J; Morgan, G J; Carding, S R
Autoimmune associated bone disease and intestinal inflammation are closely linked with deregulation and hyperactivation of autoreactive CD4 T cells. How these T cells are activated and mediate disease is not clear. Here we show that in the Interleukin 2-deficient mouse model of autoimmunity spontaneous osteopenia and colitis are caused by increased production of the ligand for receptor activator of NFkappaB (RANKL). RANKL acting via its receptor, receptor activator of NFkappaB (RANK), increases bone turnover and promotes intestinal dendritic cell (DC) survival in vivo. Modulation of RANKL-RANK interactions with exogenous recombinant osteoprotegerin (Fc-OPG) reverses skeletal abnormalities and reduces colitis by decreasing colonic DC numbers. This study identifies a common causal link between bone disease and intestinal inflammation and establishes the importance of DC in mediating colonic inflammation in vivo.
PMID: 14670302
ISSN: 1074-7613
CID: 3706532

The use of genetic microarray analysis to classify and predict prognosis in haematological malignancies

Levene, A P; Morgan, G J; Davies, F E
The introduction of microarrays offers the opportunity to examine the expression of many thousands of genes in a single experiment. Investigations in leukaemia and lymphoma have led to the identification of a number of subgroups, with a defined gene expression pattern, not previously identified by morphology, cytogenetics or molecular techniques. In many cases these expression patterns can be linked to the tumour cells normal developmental counterpart, and represent distinct disease subgroups with different clinical presentations and outcomes. The technology has also identified genes that may be important in tumour cell biology including key genes in cell proliferation, adhesion, apoptosis, and the development of drug resistance. These early studies demonstrate that genetic microarrays will be useful in classifying haematological malignancies, predicting response to treatment, predicting prognosis, and identifying novel targets for therapy.
PMID: 12890159
ISSN: 0141-9854
CID: 3705972

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936

van Dongen, J J M; Langerak, A W; Brüggemann, M; Evans, P A S; Hummel, M; Lavender, F L; Delabesse, E; Davi, F; Schuuring, E; García-Sanz, R; van Krieken, J H J M; Droese, J; González, D; Bastard, C; White, H E; Spaargaren, M; González, M; Parreira, A; Smith, J L; Morgan, G J; Kneba, M; Macintyre, E A
In a European BIOMED-2 collaborative study, multiplex PCR assays have successfully been developed and standardized for the detection of clonally rearranged immunoglobulin (Ig) and T-cell receptor (TCR) genes and the chromosome aberrations t(11;14) and t(14;18). This has resulted in 107 different primers in only 18 multiplex PCR tubes: three VH-JH, two DH-JH, two Ig kappa (IGK), one Ig lambda (IGL), three TCR beta (TCRB), two TCR gamma (TCRG), one TCR delta (TCRD), three BCL1-Ig heavy chain (IGH), and one BCL2-IGH. The PCR products of Ig/TCR genes can be analyzed for clonality assessment by heteroduplex analysis or GeneScanning. The detection rate of clonal rearrangements using the BIOMED-2 primer sets is unprecedentedly high. This is mainly based on the complementarity of the various BIOMED-2 tubes. In particular, combined application of IGH (VH-JH and DH-JH) and IGK tubes can detect virtually all clonal B-cell proliferations, even in B-cell malignancies with high levels of somatic mutations. The contribution of IGL gene rearrangements seems limited. Combined usage of the TCRB and TCRG tubes detects virtually all clonal T-cell populations, whereas the TCRD tube has added value in case of TCRgammadelta(+) T-cell proliferations. The BIOMED-2 multiplex tubes can now be used for diagnostic clonality studies as well as for the identification of PCR targets suitable for the detection of minimal residual disease.
PMID: 14671650
ISSN: 0887-6924
CID: 3706542

Atopic disease and childhood acute lymphoblastic leukemia

Schüz, Joachim; Morgan, Gareth; Böhler, Eva; Kaatsch, Peter; Michaelis, Jörg
Our objective was to test the hypothesis that the risk of childhood leukemia is associated with allergies or a family history of allergy. We used a German population-based case-control study with self-reported information on allergies of the children and their first-degree relatives. Our study included a total of 1,130 cases of acute lymphoblastic leukemia (ALL), 164 cases of acute myeloid leukemia (AML) and 2,957 controls. A major finding of our study is that hay fever, neurodermatitis and contact eczema are underrepresented within the group of children with ALL, with respective odds ratios (OR) of 0.45 (95% confidence interval [CI] 0.31-0.66) for hay fever, of 0.49 (CI 0.34-0.71) for neurodermatitis and of 0.62 (CI 0.39-0.99) for eczema, respectively. Atopic diseases, comprising hay fever, neurodermatitis and asthma, are much stronger related with a reduced risk of ALL than other allergies (OR 0.52, CI 0.40-0.67 vs. OR 0.89, CI 0.66-1.21). The strongest association is seen with an atopy in the index child; however, ALL risk is also reduced if one of the parents or a sibling had an atopic disease. No such consistent pattern is seen for AML. Our data suggest that atopy or a family history of atopy are associated with a reduced risk of childhood ALL. Recall bias remains a concern, but sensitivity analysis provided some evidence that the protective effect is unlikely to be attributable to this bias in its entirety.
PMID: 12673688
ISSN: 0020-7136
CID: 3706492

Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation

Durie, Brian G M; Kyle, Robert A; Belch, Andrew; Bensinger, William; Blade, Joan; Boccadoro, Mario; Child, J Anthony; Comenzo, Raymond; Djulbegovic, Ben; Fantl, Dorotea; Gahrton, Gosta; Harousseau, Jean Luc; Hungria, Vania; Joshua, Douglas; Ludwig, Heinz; Mehta, Jayesh; Morales, Angelina Rodrique; Morgan, Gareth; Nouel, Amara; Oken, Martin; Powles, Raymond; Roodman, David; San Miguel, Jesus; Shimizu, Kazuyuki; Singhal, Seema; Sirohi, Bhawna; Sonneveld, Pieter; Tricot, Guido; Van Ness, Brian
These consensus guidelines have been compiled with input from the Scientific Advisors of the International Myeloma Foundation. Their production involved several steps including: A 3-day Scientific Advisors meeting, during which each specific area was presented and discussed (May 2002). Review of key literature, especially randomized study results, but also Medline, Internet, Cochrane database searches, and prior guidelines (Br J Haematol 115: 522-540, 2001). Feedback from patients participating in the International Myeloma Foundation, patient programs. These guidelines encompass both the published literature and expert opinions. Recommendations based upon expert opinions are identified as such. The intent is for the guidelines to be international in scope, plus provide recommendations for both clinical practice and research approaches. 'Consensus' reflects general, although not necessarily unanimous, agreement. Details are discussed as appropriate. For convenience, the recommendations are divided into: 1. Diagnostic criteria. 2. Staging and prognostic factors. 3. Frontline therapy. 4. High-dose therapy and transplant. 5. Maintenance therapy. 6. Supportive care and management of specific complications. 7. Novel therapies and new technologies.
PMID: 14671610
ISSN: 1466-4860
CID: 3695702

CYP1A1*2B (Val) allele is overrepresented in a subgroup of acute myeloid leukemia patients with poor-risk karyotype associated with NRAS mutation, but not associated with FLT3 internal tandem duplication

Bowen, David T; Frew, Marion E; Rollinson, Sara; Roddam, Philippa L; Dring, Ann; Smith, Martyn T; Langabeer, Stephen E; Morgan, Gareth J
The etiology of acute myeloid leukemia (AML) is largely unknown. Biologic and epidemiologic data implicate exogenous toxicants, including cytotoxic drugs, benzene, radiation, and cigarette smoking. Allelic variation in genes encoding enzymes such as NADP(H) quinone oxidoreductase (NQO1) and glutathione S-transferase T1 (GSTT1) that metabolize environmental toxicants predispose to subtypes of AML, including therapy-related AML. We assayed NRAS oncogene mutation and FLT3 internal tandem duplication in 447 AML patients with an abnormal karyotype treated in Medical Research Council (MRC) AML clinical trials. Functional allelic variant frequencies in genes encoding carcinogen-metabolizing enzymes GSTT1, GSTM1, CYP1A1, CYP2D6, CYP2C19, SULT1A1, and NQO1 were previously determined for this cohort. FLT3 internal tandem duplication (ITD) frequency was 17%, and NRAS mutation 12% for the entire cohort. The 2 mutations were found together in only 4 patients. No association was found between enzyme allelic variant frequencies and the presence of FLT3 ITD for the entire cohort or within cytogenetic subgroups. CYP1A1*2B (Val) high-inducibility variant allele was overrepresented in patients with NRAS mutation compared with no mutation, for (1) the entire AML cohort (n = 8/53 vs 26/371; odds ratio [OR] = 2.36; 95% confidence interval [CI] 1.01-5.53) and (2) the poor-risk karyotype group (n = 6/14 vs 4/89; OR = 15.94; 95% CI 3.71-68.52) comprising patients with partial/complete deletion of chromosome 5 or 7, or abnormalities of chromosome 3. The CYP1A1*2B allele may predispose to the development of these subgroups of AML by augmented phase 1 metabolism to highly reactive intermediates of CYP1A1 substrates, including polycyclic aromatic hydrocarbons, or by generation of oxidative stress as a metabolic by-product.
PMID: 12468438
ISSN: 0006-4971
CID: 3649852

Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells

Podar, Klaus; Tai, Yu-Tzu; Cole, Craig E; Hideshima, Teru; Sattler, Martin; Hamblin, Angela; Mitsiades, Nicholas; Schlossman, Robert L; Davies, Faith E; Morgan, Gareth J; Munshi, Nikhil C; Chauhan, Dharminder; Anderson, Kenneth C
Caveolae, specialized flask-shaped lipid rafts on the cell surface, are composed of cholesterol, sphingolipids, and structural proteins termed caveolins; functionally, these plasma membrane microdomains have been implicated in signal transduction and transmembrane transport. In the present study, we examined the role of caveolin-1 in multiple myeloma cells. We show for the first time that caveolin-1, which is usually absent in blood cells, is expressed in multiple myeloma cells. Analysis of myeloma cell-derived plasma membrane fractions shows that caveolin-1 is co-localized with interleukin-6 receptor signal transducing chain gp130 and with insulin-like growth factor-I receptor. Cholesterol depletion by beta-cyclodextrin results in the loss of caveola structure in myeloma cells, as shown by transmission electron microscopy, and loss of caveolin-1 function. Interleukin-6 and insulin-like growth factor-I, growth and survival factors in multiple myeloma, induce caveolin-1 phosphorylation, which is abrogated by pre-treatment with beta-cyclodextrin. Importantly, inhibition of caveolin-1 phosphorylation blocks both interleukin-6-induced protein complex formation with caveolin-1 and downstream activation of the phosphatidylinositol 3-kinase/Akt-1 pathway. beta-Cyclodextrin also blocks insulin-like growth factor-I-induced tyrosine phosphorylation of insulin-responsive substrate-1 and downstream activation of the phosphatidylinositol 3-kinase/Akt-1 pathway. Therefore, cholesterol depletion by beta-cyclodextrin abrogates both interleukin-6- and insulin-like growth factor-I-triggered multiple myeloma cell survival via negative regulation of caveolin-1. Taken together, this study identifies caveolin-1 and other structural membrane components as potential new therapeutic targets in multiple myeloma.
PMID: 12482878
ISSN: 0021-9258
CID: 3649862